BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 34738072)

  • 1. Lipid-Lowering Drug Use and Cancer Incidence and Mortality in the ARIC Study.
    Marrone MT; Mondul AM; Prizment AE; Couper D; Barber JR; Chappidi MR; Joshu CE; Platz EA
    JNCI Cancer Spectr; 2021 Oct; 5(5):. PubMed ID: 34738072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in Prostate, Lung, Breast, and Colorectal Cancer Survival and Comorbidity Status among Urban American Indians and Alaskan Natives.
    Emerson MA; Banegas MP; Chawla N; Achacoso N; Alexeeff SE; Adams AS; Habel LA
    Cancer Res; 2017 Dec; 77(23):6770-6776. PubMed ID: 29187399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalent diabetes and risk of total, colorectal, prostate and breast cancers in an ageing population: meta-analysis of individual participant data from cohorts of the CHANCES consortium.
    Amadou A; Freisling H; Jenab M; Tsilidis KK; Trichopoulou A; Boffetta P; Van Guelpen B; Mokoroa O; Wilsgaard T; Kee F; Schöttker B; Ordóñez-Mena JM; Männistö S; Söderberg S; Vermeulen RCH; Quirós JR; Liao LM; Sinha R; Kuulasmaa K; Brenner H; Romieu I
    Br J Cancer; 2021 May; 124(11):1882-1890. PubMed ID: 33772152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin use and cancer risk: a comprehensive review.
    Boudreau DM; Yu O; Johnson J
    Expert Opin Drug Saf; 2010 Jul; 9(4):603-21. PubMed ID: 20377474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort study.
    Alpérovitch A; Kurth T; Bertrand M; Ancelin ML; Helmer C; Debette S; Tzourio C
    BMJ; 2015 May; 350():h2335. PubMed ID: 25989805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium.
    Ordóñez-Mena JM; Schöttker B; Mons U; Jenab M; Freisling H; Bueno-de-Mesquita B; O'Doherty MG; Scott A; Kee F; Stricker BH; Hofman A; de Keyser CE; Ruiter R; Söderberg S; Jousilahti P; Kuulasmaa K; Freedman ND; Wilsgaard T; de Groot LC; Kampman E; Håkansson N; Orsini N; Wolk A; Nilsson LM; Tjønneland A; Pająk A; Malyutina S; Kubínová R; Tamosiunas A; Bobak M; Katsoulis M; Orfanos P; Boffetta P; Trichopoulou A; Brenner H;
    BMC Med; 2016 Apr; 14():62. PubMed ID: 27044418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and prostate cancer screening, incidence, and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Hurwitz LM; Dogbe N; Barry KH; Koutros S; Berndt SI
    J Natl Cancer Inst; 2023 Dec; 115(12):1506-1514. PubMed ID: 37382561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes Medication Use in Association with Survival among Patients of Breast, Colorectal, Lung, or Gastric Cancer.
    Baglia ML; Cui Y; Zheng T; Yang G; Li H; You M; Xu L; Murff H; Gao YT; Zheng W; Xiang YB; Shu XO
    Cancer Res Treat; 2019 Apr; 51(2):538-546. PubMed ID: 29986576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the Age at Menarche with Site-Specific Cancer Risks in Pooled Data from Nine Cohorts.
    Fuhrman BJ; Moore SC; Byrne C; Makhoul I; Kitahara CM; Berrington de González A; Linet MS; Weiderpass E; Adami HO; Freedman ND; Liao LM; Matthews CE; Stolzenberg-Solomon RZ; Gaudet MM; Patel AV; Lee IM; Buring JE; Wolk A; Larsson SC; Prizment AE; Robien K; Spriggs M; Check DP; Murphy N; Gunter MJ; Van Dusen HL; Ziegler RG; Hoover RN
    Cancer Res; 2021 Apr; 81(8):2246-2255. PubMed ID: 33820799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk.
    Simon MS; Rosenberg CA; Rodabough RJ; Greenland P; Ockene I; Roy HK; Lane DS; Cauley JA; Khandekar J
    Ann Epidemiol; 2012 Jan; 22(1):17-27. PubMed ID: 22056480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cancer incidence in Australian farm residents 45 years and over, compared to rural non-farm and urban residents - a data linkage study.
    Depczynski J; Dobbins T; Armstrong B; Lower T
    BMC Cancer; 2018 Jan; 18(1):33. PubMed ID: 29304761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes-related risk factors and survival among individuals with type 2 diabetes and breast, lung, colorectal, or prostate cancer.
    Laurberg T; Witte DR; Gudbjörnsdottir S; Eliasson B; Bjerg L
    Sci Rep; 2024 May; 14(1):10956. PubMed ID: 38740921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional status declines among cancer survivors: trajectory and contributing factors.
    Petrick JL; Reeve BB; Kucharska-Newton AM; Foraker RE; Platz EA; Stearns SC; Han X; Windham BG; Irwin DE
    J Geriatr Oncol; 2014 Oct; 5(4):359-67. PubMed ID: 24981125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin and testosterone replacement therapy inversely associated with hormone-associated cancers (prostate, colorectal and male breast cancers) among older White and Black men.
    Lopez DS; Malagaris I; Polychronopoulou E; Tsilidis KK; Milani SA; Kristen Peek M; Villasante-Tezanos A; Alzweri L; Baillargeon J; Kuo YF; Canfield S
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):792-803. PubMed ID: 35902376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to the Diabetes Risk Reduction Diet and Bladder Cancer Risk in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cohort.
    Chen Y; Zeng S; Jiao B; Zhang H; Li G; Zhang X; Hu X
    Cancer Epidemiol Biomarkers Prev; 2023 Dec; 32(12):1726-1733. PubMed ID: 37721479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of diabetes and cancer mortality in American Indians: the Strong Heart Study.
    Best LG; García-Esquinas E; Yeh JL; Yeh F; Zhang Y; Lee ET; Howard BV; Farley JH; Welty TK; Rhoades DA; Rhoades ER; Umans JG; Navas-Acien A
    Cancer Causes Control; 2015 Nov; 26(11):1551-60. PubMed ID: 26250516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and cancer: mechanistic insights from transdisciplinary studies.
    Allott EH; Hursting SD
    Endocr Relat Cancer; 2015 Dec; 22(6):R365-86. PubMed ID: 26373570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol lowering drug use and breast cancer survival: the Multiethnic Cohort Study.
    Moksud N; Loo LWM; Yang J; Huang CY; Haiman CA; Le Marchand L; Wilkens LR; Cheng I
    Breast Cancer Res Treat; 2021 Nov; 190(1):165-173. PubMed ID: 34460030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of weight loss medications in relation with prostate, colorectal and male breast cancers among older men: SEER-Medicare 2007-2015.
    Lopez DS; Kim H; Polychronopoulou E; Torres-Sanchez LE; Villasante-Tezanos A; Baillargeon J; Canfield S; Kuo YF
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8255-8265. PubMed ID: 37067547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality from all cancers and lung, colorectal, breast and prostate cancer by country of birth in England and Wales, 2001-2003.
    Wild SH; Fischbacher CM; Brock A; Griffiths C; Bhopal R
    Br J Cancer; 2006 Apr; 94(7):1079-85. PubMed ID: 16523198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.